Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 13-((dimethylamino)methyl)-10,11,14,15-tetrahydro-4,9:16,21-dimetheno-1h,13h-dibenzo(e,k)pyrrolo(3,4-h)(1,4,13)oxadiazacyclohexadecene-1,3(2h)-dione
2. Arxxant
3. Ly 333531
4. Ly-333531
5. Ruboxistaurin Mesilate Hydrate
1. 169939-94-0
2. Ly-333531
3. Ruboxistaurin [inn]
4. Ly 333531
5. Ly333531
6. 721809wqcp
7. K00587a
8. (18s)-18-[(dimethylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione
9. Chembl432130
10. (9s)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9h,18h-5,21:12,17-di(metheno)dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19h)-dione
11. 9h,18h-5,21:12,17-dimethenodibenzo(e,k)pyrrolo(3,4-h)(1,4,13)oxadiazacyclohexadecine-18,20(19h)-dione, 9-((dimethylamino)methyl)-6,7,10,11-tetrahydro-, (9s)-
12. Unii-721809wqcp
13. 13-((dimethylamino)methyl)-10,11,14,15-tetrahydro-4,9:16,21-dimetheno-1h,13h-dibenzo(e,k)pyrrolo(3,4-h)(1,4,13)oxadiazacyclohexadecene-1,3(2h)-dione
14. (9r)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9h,18h-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dione
15. 9h,18h-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19h)-dione, 9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-, (9s)-
16. Ly4
17. 1uu3
18. Ruboxistaurin [mi]
19. Ruboxistaurin; Ly333531
20. Ruboxistaurin [vandf]
21. Chembl91829
22. Ruboxistaurin [mart.]
23. Ruboxistaurin [who-dd]
24. Cid_153999
25. Gtpl5263
26. Schembl2496701
27. Bdbm17055
28. Dtxsid00168775
29. Ex-a2313
30. Zinc3812168
31. Bdbm50128281
32. Nsc800873
33. Db11829
34. Nsc-800873
35. Zacyclohexadecine-18,20-dione
36. (9s)-9-((dimethylamino)methyl)-6,7,10,11-tetrahydro-9h,19h-5,21:12,17-dimethenodibenzo(e,k)pyrrolo(3,4-h)(1,4,13)oxadiazacyclohexadecene-18,20-dione
37. (s)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9h,18h-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19h)-dione
38. Ac-35844
39. Hy-10195
40. Cs-0002500
41. Ly-333,531
42. A12399
43. A902568
44. Q7376181
45. (18s)-18-[(dimethylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1;{7,14}.0;{2,6}.0;{8,13}.0;{22,27}]nonacosa-1(28),2(6),7(29),8(13),9,11,22(27),23,25-nonaene-3,5-dione
46. (9r)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9h,18h-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadia
47. 18-dimethylaminomethyl-(18s)-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8(13),9,11,22(27),23,25-nonaene-3,5-dione; Methane Sulphonic Acid Salt
| Molecular Weight | 468.5 g/mol |
|---|---|
| Molecular Formula | C28H28N4O3 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 468.21614077 g/mol |
| Monoisotopic Mass | 468.21614077 g/mol |
| Topological Polar Surface Area | 68.5 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 872 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Ruboxistaurin has known human metabolites that include N-desmethyl LY333531.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ABOUT THIS PAGE
88
PharmaCompass offers a list of Ruboxistaurin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ruboxistaurin manufacturer or Ruboxistaurin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ruboxistaurin manufacturer or Ruboxistaurin supplier.
PharmaCompass also assists you with knowing the Ruboxistaurin API Price utilized in the formulation of products. Ruboxistaurin API Price is not always fixed or binding as the Ruboxistaurin Price is obtained through a variety of data sources. The Ruboxistaurin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ruboxistaurin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ruboxistaurin, including repackagers and relabelers. The FDA regulates Ruboxistaurin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ruboxistaurin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ruboxistaurin supplier is an individual or a company that provides Ruboxistaurin active pharmaceutical ingredient (API) or Ruboxistaurin finished formulations upon request. The Ruboxistaurin suppliers may include Ruboxistaurin API manufacturers, exporters, distributors and traders.
Ruboxistaurin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ruboxistaurin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ruboxistaurin GMP manufacturer or Ruboxistaurin GMP API supplier for your needs.
A Ruboxistaurin CoA (Certificate of Analysis) is a formal document that attests to Ruboxistaurin's compliance with Ruboxistaurin specifications and serves as a tool for batch-level quality control.
Ruboxistaurin CoA mostly includes findings from lab analyses of a specific batch. For each Ruboxistaurin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ruboxistaurin may be tested according to a variety of international standards, such as European Pharmacopoeia (Ruboxistaurin EP), Ruboxistaurin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ruboxistaurin USP).
